logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
N

Ning Ren

fudan university
H指数:40
被引数:4,862

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma

Macro CD5L恶化CD8 T细胞耗竭并损害肝内胆管癌的Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1治疗组合

NATURE COMMUNICATIONS
IF15.7
2024-01-2011
OAAI
Lu, Jia-Cheng; Wu, Lei-Lei; Sun, Yi-Ning; Huang, Xiao-Yong; Gao, Chao; Guo, Xiao-Jun; Zeng, Hai-Ying; Qu, Xu-Dong; Chen, Yi; Wu, Dong; Pei, Yan-Zi; Meng, Xian-Long; Zheng, Yi-Min; Liang, Chen; Zhang, Peng-Fei; Cai, Jia-Bin; Ding, Zhen-Bin; Yang, Guo-Huan; Ren, Ning; Huang, Cheng; Wang, Xiao-Ying; Gao, Qiang; Sun, Qi-Man; Shi, Ying-Hong; Qiu, Shuang-Jian; Ke, Ai-Wu; Shi, Guo-Ming; Zhou, Jian; Sun, Yi-Di; Fan, Jia
Lenvatinib plus anti-PD-1 therapy represents a feasible conversion resection strategy for patients with initially unresectable hepatocellular carcinoma: A retrospective study

Lenvatinib联合anti-PD-1治疗对最初不可切除的肝细胞癌患者是一种可行的转换切除策略: 一项回顾性研究

FRONTIERS IN ONCOLOGY
IF3.3
2022-11-2426
OAAI
Yi, Yong; Sun, Bao-Ye; Weng, Jia-Lei; Zhou, Cheng; Zhou, Chen-Hao; Cai, Ming-Hao; Zhang, Jing-Yun; Gao, Hong; Sun, Jian; Zhou, Jian; Fan, Jia; Ren, Ning; Qiu, Shuang-Jian

研究方向

暂未获取到该数据
C
Chenhao Zhou
H 指数:29论文数:203被引数:2,603
Q
Qiongzhu Dong
H 指数:55论文数:207被引数:1.0万
Q
Qing‐Hai Ye
H 指数:51论文数:194被引数:1.0万
M
Manar Atyah
H 指数:14论文数:31被引数:809
钦
钦伦秀
H 指数:76论文数:366被引数:2.1万
H
Hu‐Liang Jia
H 指数:44论文数:151被引数:9,785
J
Jialei Weng
H 指数:15论文数:67被引数:885
Y
Yirui Yin
H 指数:11论文数:52被引数:540
W
Wanyong Chen
H 指数:14论文数:32被引数:794
H
Haijun Zhou
H 指数:25论文数:114被引数:2,791